Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression
NCT07247006Phase 2Not yet recruiting
- Sponsor
- University of Rochester
- Start
- Dec 2026
- Primary completion
- Mar 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in treatment-resistant depression (TRD), sponsored by University of Rochester. Planned start Dec 2026; status: not yet recruiting.
02
Drugs
ketamine
03
Conditions
treatment-resistant depression (TRD)
Beyond the preview
Go deeper on NCT07247006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07247006.